Shares of Sino Biopharmaceutical were the best performing among the 21 Hong Kong-listed companies that made it to Forbes’ ‘Best Over a Billion’ list. Photo: Shutterstock Shares of Sino Biopharmaceutical were the best performing among the 21 Hong Kong-listed companies that made it to Forbes’ ‘Best Over a Billion’ list. Photo: Shutterstock
Shares of Sino Biopharmaceutical were the best performing among the 21 Hong Kong-listed companies that made it to Forbes’ ‘Best Over a Billion’ list. Photo: Shutterstock

Investing

Business /  Investor Relations

21 Hong Kong-listed firms in Forbes’ inaugural list of top Asian corporates, but share prices tell a different story

  • Forbes’ inaugural ‘Best Over a Billion’ list comprises Asia’s top 200 companies with revenues of over US$1 billion
  • Average share price loss for the 21 Hong Kong companies in the list was 12.68 per cent against the Hang Seng Index decline of 7.17 per cent

Topic |   Investing
Ryan Swift
Ryan Swift

Updated: 8:30am, 3 Sep, 2019

Why you can trust SCMP
Shares of Sino Biopharmaceutical were the best performing among the 21 Hong Kong-listed companies that made it to Forbes’ ‘Best Over a Billion’ list. Photo: Shutterstock Shares of Sino Biopharmaceutical were the best performing among the 21 Hong Kong-listed companies that made it to Forbes’ ‘Best Over a Billion’ list. Photo: Shutterstock
Shares of Sino Biopharmaceutical were the best performing among the 21 Hong Kong-listed companies that made it to Forbes’ ‘Best Over a Billion’ list. Photo: Shutterstock
READ FULL ARTICLE